HOXC8 and type 2 diabetes mellitus: Thus, the miR-196a-Hoxc8-C/EBPβ pathway underlies the brown adipogenesis in WAT (Figure 8) and might be a therapeutic target for the treatment of obesity and type 2 diabetes.